Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Operating revenues:        
License revenues
Operating expenses:        
Research and development 1,874 1,070 4,481 1,861
General and administrative 867 780 1,681 1,295
Operating loss (2,741) (1,850) (6,162) (3,156)
Other (income) expense:        
Governmental assistance - research incentives (226) (118) (400) (850)
Other (income) expense (54) (13) (58) 22
Change in fair value of warrant liability 39
Total other (income) expense (280) (131) (458) (789)
Loss before income tax expense (2,461) (1,719) (5,704) (2,367)
Income tax expense 8 16 17 18
Net loss (2,469) (1,735) (5,721) (2,385)
Other comprehensive income        
Unrealized gain on marketable securities 8 11
Net loss and comprehensive loss $ (2,461) $ (1,735) $ (5,710) $ (2,385)
Basic and diluted net loss per share (in dollars per share) $ (0.21) $ (0.22) $ (0.48) $ (0.33)
Weighted average shares outstanding – basic and diluted (in shares) 11,979,401 7,821,496 11,968,200 7,187,659